electroCore, Inc. (the “Company”) (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, is thrilled to announce that it has received a license to import, distribute and market its innovative gammaCore Sapphire™, a non-invasive vagus nerve stimulator (nVNS), in Indonesia.
This follows the license approvals the Company has already received in Malaysia in September 2022 and South Africa in March 2023. This latest development shows the Company’s commitment to expanding its reach and providing its products to a growing worldwide customer base.
electroCore’s SVP of Global Sales and Strategy, Iain Strickland, expressed his excitement regarding the recent registration of gammaCore in Indonesia, South Africa, and Malaysia.
“Gaining these approvals and opening up supply routes for gammaCore not only solidifies the clinical evidence portfolio we have behind the technology, but it also expands the geographical access for patients and clinicians,” said Strickland. This marks the first time gammaCore has been registered in both the Far East and African continent.
Mr. Strickland enthused, “We are thrilled to be creating new clinician networks and we are proud to support Kromax South Asia and Byond Healthcare in their upcoming launches in the regions of South Asia and India.
With a population of 367 million, this market presents an incredible opportunity to introduce gammaCore nVNS and to collaborate with local key opinion leaders. We are deeply grateful for their support and their willingness to consider gammaCore nVNS for headache patients.”
About electroCore, Inc.
ElectroCore, Inc. is a pioneering bioelectronic medicine and wellness company that is revolutionizing healthcare outcomes through its non-invasive vagus nerve stimulation (“nVNS”) technology platform.
We are committed to providing medical devices to manage and treat medical conditions, as well as consumer products that use nVNS to promote wellbeing and performance in the US and select overseas markets. Our mission is to lead the way in this cutting-edge field and bring about a new era of healthcare.
Experience relief from your migraine and cluster headache symptoms with gammaCore™ (nVNS), the first non-invasive, hand-held medical therapy! gammaCore is a portable, easy-to-use device that stimulates the vagus nerve through the skin to reduce pain.
Unlike traditional medications, gammaCore has no potential side effects and can be administered by the patient, as needed. Simply place the device on your neck to stimulate the nerve’s afferent fibers and gain relief from your migraine and cluster headaches.
gammaCore™ is the perfect non-invasive solution for managing migraine and other headache-related conditions. This innovative device provides vagus nerve stimulation (nVNS) on the side of the neck, providing both preventive and acute treatment of migraine pain in patients 12 and older.
It is also indicated for use in the preventive treatment of cluster headache, acute treatment of episodic cluster headache, and treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Use with caution and always read the Instructions for Use for complete safety information and indications. Experience the power of gammaCore and get relief from your headache-related conditions today!